SENORES PHARMACEUTICALS L (SENORES) Share Price Hits Fresh 52-Week High

SENORES PHARMACEUTICALS L Share Price was at Rs 1520.1 on 17 August 2026 at 12:16 PM IST, up Rs 42.9 or 2.9% from the previous close of Rs 1477.2, after touching a fresh 52-week high of Rs 1522. The company’s market capitalisation stood at Rs 6,803.04 crore, putting the move firmly on the radar in today’s Stock Market Today and Share Market Today screens.

The verified data confirms a fresh one-year high event in SENORES PHARMACEUTICALS L Share Price Today. It also shows that the stock traded within a session range of Rs 1474.5 to Rs 1522 after opening at Rs 1494.2, with turnover of Rs 1.52 crore and volume of 10,026 shares. That combination makes the move relevant from a price-action perspective even though the supplied data does not establish a company-specific catalyst.

For investors tracking SENORES PHARMACEUTICALS L Stock News, the immediate questions are straightforward: what exactly happened in today’s trade, how does the valuation compare with the Healthcare sector benchmark, and whether the company’s profitability metrics support the attention created by this 52-week peak. Univest analysis of the supplied figures suggests a strong price milestone, but a mixed fundamental backdrop that deserves close monitoring.

SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,520.1
Previous Close	Rs 1,477.2
Today's Change	+Rs 42.9 (+2.9%)
Day Open	Rs 1,494.2
Fresh 52-Week High	Rs 1,522
Day Low	Rs 1,474.5
Current Volume	10,026
Turnover	Rs 1.52 crore
Market Capitalisation	Rs 6,803.04 crore

SENORES PHARMACEUTICALS L (SENORES) traded at Rs 1,520.1. versus the previous close of Rs 1,477.2, a rise of 2.9%. The stock opened at Rs 1,494.2, reached Rs 1,522, touched Rs 1,474.5. Reported volume was 10,026.

SENORES PHARMACEUTICALS L Share Price Today reflects a confirmed breakout to a fresh 52-week high, with the stock nearing its session peak by midday. The move shows clear intraday strength versus the previous close, while turnover and traded volume indicate the stock is drawing attention as one of the 52 Week High Stocks in Market News.

SENORES PHARMACEUTICALS L Share Price opened at Rs 1494.2, above the previous close of Rs 1477.2, and extended gains to an intraday high of Rs 1522. The stock later traded at Rs 1520.1, still close to the day’s top and up Rs 42.9, or 2.9%, on the session. The intraday low was Rs 1474.5, which means the stock recovered well from near the lower end of the day’s range and sustained its move toward the yearly high.

Turnover stood at Rs 1.52 crore, while 10,026 shares changed hands. In practical terms, that confirms live participation in the move and helps explain why SENORES PHARMACEUTICALS L Share News is appearing among Stocks in News and Market Movers screens. The supplied data verifies the price event itself: the stock touched Rs 1522 and set a fresh 52-week peak. What it does not establish is a specific corporate trigger behind the move.

From a price-action standpoint, the most notable feature is that SENORES PHARMACEUTICALS L Share Price Live remained very close to the session high after crossing the one-year high mark. That generally keeps trader focus on the stock’s ability to hold above breakout levels in the remainder of the session, which is why the next step is to examine whether fundamentals support sustained investor attention.

SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,803.04 crore
P/E Ratio	184.72x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

SENORES PHARMACEUTICALS L was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	184.72x
Benchmark Median P/E	21.1x
Benchmark Average P/E	49.38x
Benchmark P/E Range	0x to 1,603.4x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.71%
Company ROCE	-0.26%
Benchmark Median ROCE	13.15%
Company Market Capitalisation	Rs 6,803.04 crore
Benchmark Median Market Cap	Rs 135.27 crore

SENORES PHARMACEUTICALS L (SENORES) is classified under sector: Healthcare.

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SENORES PHARMACEUTICALS L (SENORES) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	58.41	8.73	11.42	13.15

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,803.04 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching SENORES PHARMACEUTICALS L

The stock is drawing attention because the verified data combines a clear price milestone with a valuation and sector profile that is not one-dimensional. For investors following SENORES PHARMACEUTICALS L Stock News, these are the main reasons it is on the radar today.

• SENORES PHARMACEUTICALS L Share Price rose 2.9% to Rs 1520.1 and touched a fresh 52-week high of Rs 1522.
• The stock traded above its previous close of Rs 1477.2 after opening at Rs 1494.2, with an intraday range of Rs 1474.5 to Rs 1522.
• Turnover of Rs 1.52 crore and volume of 10,026 shares confirm active session participation in today’s Share Price Update.
• The company’s market capitalisation of Rs 6,803.04 crore stands above the supplied Healthcare benchmark average and median.
• The P/E ratio of 184.72 is above the sector median of 21.1 and average of 49.38, while P/B at 0.45 is below sector central levels.
• ROE of -2.89% and ROCE of -0.26% remain below the Healthcare benchmark, adding fundamental context to the latest price action.

About SENORES PHARMACEUTICALS L

SENORES PHARMACEUTICALS L, traded under the symbol SENORES, is part of the Healthcare sector according to the supplied data. In the context of SENORES PHARMACEUTICALS L Company News and market tracking, the most important verified identity points are its listed status, its Healthcare classification and its current market capitalisation of Rs 6,803.04 crore.

Because the supplied company dataset for this article is event-led rather than business-description led, investors are currently interacting with SENORES PHARMACEUTICALS L primarily through market data: its latest Share Price, valuation ratios, profitability ratios and position versus sector peers. That makes SENORES PHARMACEUTICALS L Share Price Today, SENORES PHARMACEUTICALS L Shareholding Pattern searches, and broader Stock Performance analysis especially relevant on platforms such as Univest when the stock hits a fresh 52 Week High.

Track SENORES PHARMACEUTICALS L Share Price on Univest

Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking SENORES PHARMACEUTICALS L Share Price can use Univest to follow live share price movement, 52-week levels, market cap trends, valuation ratios, sector comparison and broader market insights. For event-led moves such as today’s fresh one-year high, Univest helps place raw price action beside fundamental context.

That matters because SENORES PHARMACEUTICALS L Share Price Today is not just about the latest tick. It also involves how the stock compares with Healthcare sector benchmarks on P/E, P/B, ROE, ROCE and market capitalisation, and how it ranks among peers in current Stock Updates and Market Trends.

Frequently Asked Questions

What is the latest SENORES PHARMACEUTICALS L Share Price Today?

Ans. SENORES PHARMACEUTICALS L Share Price Today was Rs 1520.1 at 12:16 PM IST on 17 August 2026. The stock was up Rs 42.9, or 2.9%, from the previous close of Rs 1477.2.

Did SENORES PHARMACEUTICALS L hit a fresh 52-week high today?

Ans. Yes, SENORES PHARMACEUTICALS L Share Price touched a fresh 52-week high of Rs 1522 during the session. It later traded at Rs 1520.1, remaining close to the day’s high and confirming the one-year high event.

Why is SENORES PHARMACEUTICALS L rising today?

Ans. The supplied data confirms that SENORES PHARMACEUTICALS L Share Price rose 2.9% and reached a fresh 52-week high. It verifies the price event, turnover of Rs 1.52 crore and volume of 10,026 shares, but not a company-specific catalyst.

What was the intraday range for SENORES PHARMACEUTICALS L today?

Ans. SENORES PHARMACEUTICALS L traded between Rs 1474.5 and Rs 1522 in today’s session. The stock opened at Rs 1494.2, crossed its previous close of Rs 1477.2 and moved to a fresh yearly high.

What is the market capitalisation of SENORES PHARMACEUTICALS L?

Ans. SENORES PHARMACEUTICALS L had a market capitalisation of Rs 6,803.04 crore at the time of the update. That is above the Healthcare sector benchmark average of Rs 456.49 crore and median of Rs 135.27 crore.

How expensive is SENORES PHARMACEUTICALS L on P/E basis?

Ans. SENORES PHARMACEUTICALS L trades at a P/E ratio of 184.72. This is above the Healthcare sector median P/E of 21.1 and the average of 49.38, placing it at a relatively elevated earnings multiple.

What does the P/B ratio of SENORES PHARMACEUTICALS L show?

Ans. SENORES PHARMACEUTICALS L has a P/B ratio of 0.45. That is below the Healthcare sector median of 1.9 and average of 2.3, showing a lower price-to-book reading than sector central levels.

How do SENORES PHARMACEUTICALS L profitability ratios compare with the sector?

Ans. SENORES PHARMACEUTICALS L reports ROE of -2.89% and ROCE of -0.26%. Both are below the Healthcare sector median levels of 10.71% for ROE and 13.15% for ROCE in the supplied benchmark.

How does SENORES PHARMACEUTICALS L compare with peers?

Ans. SENORES PHARMACEUTICALS L has a larger market cap than supplied peers such as Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals. Its P/E is higher than most of them, while P/B is lower.

Why is SENORES PHARMACEUTICALS L Share Price attracting attention on Univest?

Ans. SENORES PHARMACEUTICALS L Share Price is attracting attention on Univest because it hit a fresh 52-week high, gained 2.9% in the session, and presents a notable mix of large market cap, high P/E and weak return ratios.